Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials: Atlanta Saturday, August 9, 2025, 18:00 Hrs [IST] Dogwood Therapeutics Inc, a d ...

Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia: Forte Lee, New Jersey Saturday, August 9, 2025, 17:00 Hrs ...

ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada: Toronto Saturday, August 9, 2025, 16:00 Hrs [IST] ProteinQure, a ...

Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...

The government has announced the appointment of Professor Susan Hopkins as the new chief executive officer (CEO) of the UK Health Security Agency (UKHSA). This follows a fair and open recruitment ...